ArticleTransplantation and cellular therapy2022

Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel.

Jonas W Ravich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.